Target intelligence / Profile preview

Inflammatory system

Molecular classification
Cytokine, Chemokine, Enzyme, G protein-coupled receptor, Transcription factor, Receptor, Other
01

Overview

The inflammatory system is a multifaceted biological network comprising various cell types, signaling proteins, and physiological processes designed to protect the host from pathogens and initiate tissue repair [StatPearls: NBK493173]. It operates through a coordinated cascade of events involving the recognition of harmful stimuli, the release of inflammatory mediators like cytokines and prostaglandins, and the recruitment of immune cells to the site of injury or infection [Nature: 10.1038/nature07201]. While acute inflammation is a vital defense mechanism, chronic or dysregulated activation of this system is a primary driver of numerous pathologies, including rheumatoid arthritis, inflammatory bowel disease, and atherosclerosis [NIH: PMC3492709]. Pharmacological intervention does not target the system as a whole but rather focuses on specific molecular nodes, such as TNF-alpha or COX-2, to alleviate symptoms and prevent tissue damage [PubChem: CID 3672]. Balancing the suppression of pathological inflammation with the maintenance of protective immunity remains a central challenge in drug development [Science: 10.1126/science.1213859].

Other names
Inflammatory responseInnate immune systemImmune systemInflammationInflammatory cascade
02

Mechanism of action

Pharmacological agents modulate the inflammatory system by inhibiting key enzymes such as cyclooxygenase (COX-1/2), blocking cytokine signaling through monoclonal antibodies (e.g., anti-TNF, anti-IL-6R), or activating glucocorticoid receptors to suppress the transcription of pro-inflammatory genes [StatPearls: NBK493173, PubChem: CID 3672, NIH: PMC3492709].

03

Biological functions

Immune responseTissue repairPathogen clearanceHomeostasisCell deathOther
04

Disease associations

InflammationAutoimmune diseaseCancerCardiovascular diseaseNeurodegenerative diseaseInfectionOther
05

Safety considerations

Increased risk of opportunistic infectionsGastrointestinal bleedingImpaired wound healingSystemic immunosuppression
06

Interacting drugs

Ibuprofen

4 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Erythrocyte sedimentation rate (ESR)Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-alpha)

Beyond the preview

Go deeper on Inflammatory system.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inflammatory system.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call